New Alzheimer’s Drug Donanemab Offers Hope for Treating Dementia
A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough in treating the disease. In a large-scale clinical trial sponsored by pharmaceutical company Eli Lilly, the antibody-based medicine was shown to slow the decline in memory, thinking, and reasoning skills that are the hallmarks of Alzheimer’s. While not a cure, […]